JP2019510226A - 線維筋痛症感受性試験の組成物、デバイスおよび方法 - Google Patents

線維筋痛症感受性試験の組成物、デバイスおよび方法 Download PDF

Info

Publication number
JP2019510226A
JP2019510226A JP2018548869A JP2018548869A JP2019510226A JP 2019510226 A JP2019510226 A JP 2019510226A JP 2018548869 A JP2018548869 A JP 2018548869A JP 2018548869 A JP2018548869 A JP 2018548869A JP 2019510226 A JP2019510226 A JP 2019510226A
Authority
JP
Japan
Prior art keywords
value
food
less
determined
food preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018548869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019510226A5 (cg-RX-API-DMAC7.html
Inventor
イラニ‐コーヘン，ザッカリー
レーダーマン，エリザベス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerica Inc
Original Assignee
Biomerica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerica Inc filed Critical Biomerica Inc
Publication of JP2019510226A publication Critical patent/JP2019510226A/ja
Publication of JP2019510226A5 publication Critical patent/JP2019510226A5/ja
Priority to JP2021201193A priority Critical patent/JP2022022426A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
JP2018548869A 2016-03-15 2017-03-14 線維筋痛症感受性試験の組成物、デバイスおよび方法 Pending JP2019510226A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021201193A JP2022022426A (ja) 2016-03-15 2021-12-10 線維筋痛症感受性試験の組成物、デバイスおよび方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662308348P 2016-03-15 2016-03-15
US62/308,348 2016-03-15
PCT/US2017/022349 WO2017160869A1 (en) 2016-03-15 2017-03-14 Compositions, devices, and methods of fibromyalgia sensitivity testing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021201193A Division JP2022022426A (ja) 2016-03-15 2021-12-10 線維筋痛症感受性試験の組成物、デバイスおよび方法

Publications (2)

Publication Number Publication Date
JP2019510226A true JP2019510226A (ja) 2019-04-11
JP2019510226A5 JP2019510226A5 (cg-RX-API-DMAC7.html) 2020-04-23

Family

ID=59850607

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018548869A Pending JP2019510226A (ja) 2016-03-15 2017-03-14 線維筋痛症感受性試験の組成物、デバイスおよび方法
JP2021201193A Pending JP2022022426A (ja) 2016-03-15 2021-12-10 線維筋痛症感受性試験の組成物、デバイスおよび方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021201193A Pending JP2022022426A (ja) 2016-03-15 2021-12-10 線維筋痛症感受性試験の組成物、デバイスおよび方法

Country Status (8)

Country Link
US (1) US20190145972A1 (cg-RX-API-DMAC7.html)
EP (1) EP3430403A4 (cg-RX-API-DMAC7.html)
JP (2) JP2019510226A (cg-RX-API-DMAC7.html)
CN (1) CN109073648A (cg-RX-API-DMAC7.html)
AU (1) AU2017235312A1 (cg-RX-API-DMAC7.html)
CA (1) CA3056368A1 (cg-RX-API-DMAC7.html)
MX (1) MX2018011166A (cg-RX-API-DMAC7.html)
WO (1) WO2017160869A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022022426A (ja) * 2016-03-15 2022-02-03 バイオメリカ・インコーポレイテッド 線維筋痛症感受性試験の組成物、デバイスおよび方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3940380A1 (en) 2014-11-14 2022-01-19 Biomerica Inc. Compositions, devices, and methods of ibs sensitivity testing
JP6943479B2 (ja) 2016-07-08 2021-09-29 バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． うつ病感受性試験の組成物、デバイスおよび方法
WO2022133467A1 (en) 2020-12-17 2022-06-23 Cummins Inc. Combustion cylinder end face components including thermal barrier coatings

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070122840A1 (en) * 2003-05-08 2007-05-31 Cousins Peter D G Assay panel comprising food allergens
US7601509B2 (en) * 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689569B2 (en) * 2001-08-14 2004-02-10 Immunosciences Lab., Inc. Saliva test for detection of food allergy, candidiasis, microflora imbalance, intestinal barrier dysfunction and humoral immunodeficiencies
CN101166760A (zh) * 2005-02-15 2008-04-23 阿波罗生命科学有限公司 分子及其嵌合分子
DE202006009206U1 (de) * 2006-03-14 2007-03-29 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Testbestecks zur Bestimmung von neuroendokrinen gesundheitlichen Störungen
US20100227340A1 (en) * 2007-09-10 2010-09-09 Immunohealth International, Llc Method of analysis, detection and correction of food intolerance in humans
EP2730662A1 (en) * 2008-11-12 2014-05-14 Caris Life Sciences Luxembourg Holdings Methods and systems of using exosomes for determining phenotypes
CN102438468B (zh) * 2009-04-17 2014-06-04 纳塔克制药有限公司 富含低含量植烷酸的ω-3脂肪酸的组合物
GB201002601D0 (en) * 2010-02-16 2010-03-31 Microtest Matrices Ltd Allergen microarray
HUE035000T2 (en) * 2010-09-29 2018-03-28 Uti Lp A method of treating autoimmune disease using biocompatible bioabsorbable nanospheres
CN103327992B (zh) * 2010-12-03 2016-10-12 信一制药株式会社 用于预防或治疗炎性疾病的包含络石藤提取物和牡丹皮提取物的药物组合物以及制备该药物组合物的方法
GB2490652A (en) * 2011-04-18 2012-11-14 Microtest Matrices Ltd Methods of quantifying antibodies, especially IgE antibodies in a sample
US20130149336A1 (en) * 2011-10-27 2013-06-13 Brian L. Hjelle Methods for Screening Viral Like Particles and Identifying Neutralizing Epitopes and Related Vaccines, Constructs, and Libraries
AU2013216983A1 (en) * 2012-02-07 2014-09-18 La Jolla Institute For Allergy And Immunology Epitopes from allergen proteins and methods and uses for immune response modulation
EP2657707A1 (en) * 2012-04-26 2013-10-30 B.R.A.H.M.S GmbH Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope
JP6285923B2 (ja) * 2012-06-22 2018-02-28 トラスティーズ・オブ・ダートマス・カレッジ 新規ＶＩＳＴＡ−Ｉｇコンストラクト及び自己免疫、アレルギー性及び炎症性障害の処置のためのＶＩＳＴＡ−Ｉｇの使用
CN202814976U (zh) * 2012-07-31 2013-03-20 白仲虎 一种用于食品不耐受性检测的检测组件
CN110187122A (zh) * 2012-09-05 2019-08-30 亚利桑那州评议委员会,亚利桑那州法人团体,代理和代表亚利桑那州立大学 发现治疗靶标的方法
WO2014066894A1 (en) * 2012-10-26 2014-05-01 Case Western Reserve University Biomarkers for nod2 and/or rip2 activity related application
WO2014182932A1 (en) * 2013-05-08 2014-11-13 The Board Of Trustees Of The Leland Stanford Junior University Methods of testing for allergen sensitivity
EP3940380A1 (en) * 2014-11-14 2022-01-19 Biomerica Inc. Compositions, devices, and methods of ibs sensitivity testing
EP3430403A4 (en) * 2016-03-15 2019-08-14 Biomerica Inc. COMPOSITIONS, DEVICES AND METHODS FOR TESTING SENSITIVITY IN FIBROMYALGIA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070122840A1 (en) * 2003-05-08 2007-05-31 Cousins Peter D G Assay panel comprising food allergens
US7601509B2 (en) * 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BATISTA EMMANUELLE DIAS ET AL.: "Food intake assessment and quality of life in women with fibromyalgia", REVISTA BRASILEIRA DE REUMATOLOGIA, vol. 56, no. 2, JPN6021002610, 2016, pages 105 - 110, ISSN: 0004439359 *
松本美富士: "線維筋痛症の疫学", PHARMA MEDICA, vol. 24, no. 6, JPN6021002611, 10 June 2006 (2006-06-10), pages 35 - 39, ISSN: 0004566881 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022022426A (ja) * 2016-03-15 2022-02-03 バイオメリカ・インコーポレイテッド 線維筋痛症感受性試験の組成物、デバイスおよび方法

Also Published As

Publication number Publication date
CA3056368A1 (en) 2017-09-21
EP3430403A1 (en) 2019-01-23
US20190145972A1 (en) 2019-05-16
WO2017160869A1 (en) 2017-09-21
EP3430403A4 (en) 2019-08-14
CN109073648A (zh) 2018-12-21
MX2018011166A (es) 2019-03-28
JP2022022426A (ja) 2022-02-03
AU2017235312A1 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
JP6681907B2 (ja) Ｉｂｓ感受性試験の組成物、デバイスおよび方法
JP7437045B2 (ja) 変形性関節症の感受性試験の組成物、装置および方法
JP7176791B2 (ja) うつ病感受性試験の組成物、デバイスおよび方法
JP2022022426A (ja) 線維筋痛症感受性試験の組成物、デバイスおよび方法
JP2024060100A (ja) 潰瘍性大腸炎患者における食物感受性の検査キットパネルの作成方法
JP2022125268A (ja) 胃食道逆流性疾患感受性試験の組成物、デバイスおよび方法
JP2022031342A (ja) 機能性消化不良感受性試験の組成物、デバイスおよび方法
JP2022022427A (ja) クローン病感受性試験の組成物、デバイスおよび方法
EP3394623B1 (en) Compositions, devices, and methods of psoriasis food sensitivity testing
EP3394617B1 (en) Compositions, devices, and methods of migraine headache food sensitivity testing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200313

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200313

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210209

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20210507

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210810

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211210

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20211210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211215

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20220118

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220314

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220315

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20220408

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20220412

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220712

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20221108

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20221206

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20221206